A narrow, specific population
CGM qualification requires a diabetes diagnosis and usually a management method meeting payer criteria. This is a much smaller population than general DME, which changes how you staff: fewer dials produce a qualified contact, so agents need to work lists efficiently rather than expecting broad hit rates.
Screening without advising
Agents ask the approved clinical screening questions and record answers verbatim. They do not explain what a given answer means, do not indicate eligibility, and do not discuss whether a device would help. The same medical-claims line that governs DME applies here in full.
Insurance qualification
Coverage screening is a mandatory criterion rather than a nice-to-have, because the economics of the transfer depend on it entirely. Campaigns publish which coverage types qualify, and transfers outside those are non-billable regardless of clinical fit.
Where centers go wrong
The most common failure is agents softening the screening to increase transfer volume — accepting a vague answer on diagnosis or management method rather than recording what the patient actually said. Buyers detect this quickly through clinical review, and it is treated as a quality breach rather than an honest mistake.